EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Current Status and Perspectives on Recurrent IgA Nephropathy after Kidney Transplantation

Mayuko Kawabe, Izumi Yamamoto

Nephron · 2023 · 147 (Suppl. 1) · 9-13

DOI: 10.1159/000530341 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nephron, online erschienen am 24.03.2023. Verfasst von Mayuko Kawabe und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan, mayuko@jikei.ac.jp. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Kidney Transplantation, Kidney Failure, Chronic. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IgA nephropathy (IgAN) is the most common form of glomerulonephritis worldwide. IgAN progresses to end-stage kidney disease in 20–40% of patients within 20 years of diagnosis. Kidney transplantation is the most effective option for patients with end-stage kidney disease caused by IgAN, but recurrence can occur in the transplanted kidney. The IgAN recurrence rate varies from 1% to 10% per year and varies according to the follow-up period, diagnostic modality, and biopsy criteria. Of note, studies based on protocol biopsies have reported a higher incidence of recurrence, which also occurred earlier after transplantation. In addition, recent data show that recurrence of IgAN is a more significant cause of allograft failure than previously believed. Little is known about the pathophysiology of IgAN recurrence, but several potential biomarkers have been investigated. Among them, galactose-deficient IgA1 (Gd-IgA1), IgG anti-Gd-IgA1 antibodies, and soluble CD89 could play a pivotal role in disease activity. This review aims to describe the current status of recurrent IgAN, including the incidence, clinical characteristics, risk factors, and future perspectives, with a focus on the available therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, IGAKidney TransplantationKidney Failure, ChronicHumansImmunoglobulin A

Stichwörter der Autor:innen

Allograft failureGalactose-deficient IgA1IgA nephropathyRecurrence glomerulonephritis

Substanzen

galactosyl-deficient IgA1Immunoglobulin A

Autor:innen und Institutionen

  • Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan, mayuko@jikei.ac.jp.
  • Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.

Zitieren

APA

Kawabe, M., & Yamamoto, I. (2023). Current Status and Perspectives on Recurrent IgA Nephropathy after Kidney Transplantation. Nephron, 147(Suppl. 1), 9-13. https://doi.org/10.1159/000530341

Vancouver

Kawabe M, Yamamoto I. Current Status and Perspectives on Recurrent IgA Nephropathy after Kidney Transplantation. Nephron. 2023;147(Suppl. 1):9-13. doi:10.1159/000530341

BibTeX
@article{Kawabe2023,
  author = {Kawabe, Mayuko and Yamamoto, Izumi},
  title = {Current Status and Perspectives on Recurrent IgA Nephropathy after Kidney Transplantation},
  journal = {Nephron},
  year = {2023},
  volume = {147},
  number = {Suppl. 1},
  pages = {9--13},
  doi = {10.1159/000530341}
}
Kostenlos starten →